Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL-Reference-Cited by-同舟云学术

Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL

Published:2019-05-02 Issue:9 Volume:4 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Geyer Mark B.^ORCID,Rivière Isabelle,Sénéchal Brigitte,Wang Xiuyan,Wang Yongzeng,Purdon Terence J.,Hsu Meier,Devlin Sean M.,Palomba M. Lia,Halton Elizabeth,Bernal Yvette^ORCID,van Leeuwen Dayenne G.,Sadelain Michel,Park Jae H.^ORCID,Brentjens Renier J.

Funder

National Cancer Institute

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/122627/files/pdf

Reference57 articles.

1. Chronic lymphocytic leukemia

2. Howlader N, et al, eds. SEER Cancer Statistics Review, 1975-2014. https://seer.cancer.gov/csr/1975_2014/ Updated April 2, 2019. Accessed April 2, 2019

3. Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia

4. Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia

5. Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric antigen receptor T‐cell therapy for haematological malignancies: Insights from fundamental and translational research to bedside practice;British Journal of Haematology;2024-09-11

2. Cancer immunotherapy and its facilitation by nanomedicine;Biomarker Research;2024-08-03

3. Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma;Journal for ImmunoTherapy of Cancer;2024-07

4. Stem cell-derived CAR T cells show greater persistence, trafficking, and viral control compared to ex vivo transduced CAR T cells;Molecular Therapy;2024-04

5. B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis;EMBO Molecular Medicine;2024-02-26